← Open Payments lookup

KATELYN KRENS: Open Payments

NPI 1922474865 · EBENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,170 in 142 payments from 12 companies in 2025. Trend: 2023 $1,560 · 2024 $1,596 · 2025 $2,170

Food & beverage: $2,170
CompanyPaymentsAmount
ABBVIE INC.70$846
Otsuka America Pharmaceutical, Inc.20$350
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$308
Alkermes, Inc.10$159
E.R. Squibb & Sons, L.L.C.10$138
Lundbeck LLC7$135
Teva Pharmaceuticals USA, Inc.4$79
Janssen Pharmaceuticals, Inc4$66
Neurocrine BioSciences, Inc.2$36
Vanda Pharmaceuticals Inc.1$22

Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across PA — which companies pay providers there.